Catherine Maari

Featured in: Favicon

springer.com Favicon

jamanetwork.com Favicon

onlinelibrary.wiley.com

Articles

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial

Aug 21, 2024 | jamanetwork.com | April Armstrong |Melinda Gooderham |Charles W. Lynde |Catherine Maari

Key PointsQuestion Is zasocitinib effective and sufficiently safe for treating psoriasis?

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →